Eleonora Scarlata

4.2k total citations
33 papers, 749 citations indexed

About

Eleonora Scarlata is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Eleonora Scarlata has authored 33 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Eleonora Scarlata's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (8 papers). Eleonora Scarlata is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Cancer Genomics and Diagnostics (8 papers). Eleonora Scarlata collaborates with scholars based in Canada, United States and France. Eleonora Scarlata's co-authors include Cristián O’Flaherty, Simone Chevalier, Lucie Hamel, Armen Aprikian, Fadi Brimo, Jacques Lapointe, Wassim Kassouf, José João Mansure, María Celia Fernández and Amina Zoubeidi and has published in prestigious journals such as Genes & Development, Oncogene and Scientific Reports.

In The Last Decade

Eleonora Scarlata

32 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleonora Scarlata Canada 15 324 221 140 121 101 33 749
Fermín Rodríguez de Bethencourt Spain 17 359 1.1× 205 0.9× 147 1.1× 64 0.5× 140 1.4× 32 717
Ming Zeng China 17 512 1.6× 74 0.3× 155 1.1× 120 1.0× 82 0.8× 44 971
Hongbo Wang China 16 471 1.5× 144 0.7× 229 1.6× 154 1.3× 98 1.0× 53 933
Jianshi Yu United States 20 668 2.1× 86 0.4× 150 1.1× 42 0.3× 172 1.7× 47 1.1k
Hua Yuan China 10 323 1.0× 45 0.2× 76 0.5× 70 0.6× 94 0.9× 32 791
Guo Dai China 17 575 1.8× 69 0.3× 336 2.4× 40 0.3× 124 1.2× 34 932
Maryam Rezaei Iran 19 450 1.4× 63 0.3× 261 1.9× 25 0.2× 137 1.4× 52 840
Chul-Koo Cho South Korea 16 336 1.0× 88 0.4× 85 0.6× 86 0.7× 107 1.1× 33 817

Countries citing papers authored by Eleonora Scarlata

Since Specialization
Citations

This map shows the geographic impact of Eleonora Scarlata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Scarlata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Scarlata more than expected).

Fields of papers citing papers by Eleonora Scarlata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Scarlata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Scarlata. The network helps show where Eleonora Scarlata may publish in the future.

Co-authorship network of co-authors of Eleonora Scarlata

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Scarlata. A scholar is included among the top collaborators of Eleonora Scarlata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Scarlata. Eleonora Scarlata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scarlata, Eleonora, et al.. (2023). Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression. The Journal of Pathology Clinical Research. 9(4). 285–301. 4 indexed citations
2.
Ebrahimizadeh, Walead, Karl‐Philippe Guérard, Eleonora Scarlata, et al.. (2020). Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification–Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples. Journal of Molecular Diagnostics. 22(10). 1246–1263. 5 indexed citations
3.
Scarlata, Eleonora, María Celia Fernández, & Cristián O’Flaherty. (2020). A Novel Combination of γ-Tocopherol-Rich Mixture of Tocopherols and Ascorbic Acid Restores Fertility in Cases of Tyrosine Nitration-Associated Male Infertility in Mice. Antioxidants. 9(7). 613–613. 7 indexed citations
4.
Scarlata, Eleonora, et al.. (2020). Long-Term Adverse Effects of Oxidative Stress on Rat Epididymis and Spermatozoa. Antioxidants. 9(2). 170–170. 55 indexed citations
5.
Scarlata, Eleonora & Cristián O’Flaherty. (2019). Antioxidant Enzymes and Male Fertility: Lessons from Knockout Models. Antioxidants and Redox Signaling. 32(8). 569–580. 34 indexed citations
6.
Brimo, Fadi, Eleonora Scarlata, Lucie Hamel, et al.. (2019). Improving ultrasound-based prostate volume estimation. BMC Urology. 19(1). 68–68. 17 indexed citations
7.
Keser, Vafa, Youngshin Lim, Eleonora Scarlata, et al.. (2019). Snap29 mutant mice recapitulate neurological and ophthalmological abnormalities associated with 22q11 and CEDNIK syndrome. Communications Biology. 2(1). 375–375. 10 indexed citations
8.
Wissing, Michel D., Simone Chevalier, Ginette McKercher, et al.. (2018). The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer. World Journal of Urology. 37(5). 789–798. 6 indexed citations
9.
Wissing, Michel D., Fadi Brimo, Simone Chevalier, et al.. (2018). Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer. British Journal of Urology. 123(4). 624–631. 12 indexed citations
10.
Rochette, Annie, Nadia Boufaied, Eleonora Scarlata, et al.. (2017). Asporin is a stromally expressed marker associated with prostate cancer progression. British Journal of Cancer. 116(6). 775–784. 48 indexed citations
11.
Audet‐Walsh, Étienne, Catherine R. Dufour, Tracey Yee, et al.. (2017). Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer. Genes & Development. 31(12). 1228–1242. 98 indexed citations
12.
Moawad, Adel R., María Celia Fernández, Eleonora Scarlata, et al.. (2017). Deficiency of peroxiredoxin 6 or inhibition of its phospholipase A2 activity impair the in vitro sperm fertilizing competence in mice. Scientific Reports. 7(1). 12994–12994. 38 indexed citations
13.
Brimo, Fadi, Bin Xu, Eleonora Scarlata, et al.. (2014). Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy. Human Pathology. 45(10). 2006–2013. 3 indexed citations
14.
Brimo, Fadi, Armen Aprikian, Mathieu Latour, et al.. (2013). Strategies for Biochemical and Pathologic Quality Assurance in a Large Multi-Institutional Biorepository; The Experience of the PROCURE Quebec Prostate Cancer Biobank. Biopreservation and Biobanking. 11(5). 285–290. 14 indexed citations
15.
Chevalier, Simone, Fabio Cury, Eleonora Scarlata, et al.. (2013). Endoscopic Vascular Targeted Photodynamic Therapy with the Photosensitizer WST11 for Benign Prostatic Hyperplasia in the Preclinical Dog Model. The Journal of Urology. 190(5). 1946–1953. 10 indexed citations
16.
Zoubeidi, Amina, Lucie Hamel, Eleonora Scarlata, et al.. (2013). The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer. Molecular and Cellular Endocrinology. 381(1-2). 140–149. 25 indexed citations
17.
Choucair, Khalil, Karl‐Philippe Guérard, Simone Chevalier, et al.. (2012). The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression. Translational Oncology. 5(6). 453–460. 35 indexed citations
18.
Anidjar, Maurice, et al.. (2011). Refining the orthotopic dog prostate cancer (DPC)‐1 model to better bridge the gap between rodents and men. The Prostate. 72(7). 752–761. 14 indexed citations
19.
Karsenty, G., Simone Chevalier, Eleonora Scarlata, et al.. (2009). Botulinum Toxin Type A Inhibits the Growth of LNCaP Human Prostate Cancer Cells In Vitro and In Vivo. The Prostate. 69(11). 1143–1150. 45 indexed citations
20.
Mansure, José João, et al.. (2009). Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer. Cancer Biology & Therapy. 8(24). 2339–2347. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fermín Rodríguez de Bethencourt Breakdown of academic impact, for papers by Ming Zeng Breakdown of academic impact, for papers by Hongbo Wang Breakdown of academic impact, for papers by Jianshi Yu Breakdown of academic impact, for papers by Hua Yuan Breakdown of academic impact, for papers by Guo Dai Breakdown of academic impact, for papers by Maryam Rezaei Breakdown of academic impact, for papers by Chul-Koo Cho
Rankless by CCL
2026